Christopher Salerno to Heart Failure
This is a "connection" page, showing publications Christopher Salerno has written about Heart Failure.
Connection Strength
5.642
-
Elective HeartWare HVAD to HeartMate 3 Pump Exchange: Risk Mitigation or Increasing Risk? Ann Thorac Surg. 2023 08; 116(2):438-440.
Score: 0.449
-
HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations. Eur J Cardiothorac Surg. 2022 06 15; 62(1).
Score: 0.433
-
HVAD to HeartMate 3 Left Ventricular Assist Device Exchange: Best Practices Recommendations. Ann Thorac Surg. 2022 06; 113(6):1770-1777.
Score: 0.426
-
Clinical distancing of hospitalized patients with advanced heart failure and cardiac transplantation during COVID-19. J Heart Lung Transplant. 2020 07; 39(7):730.
Score: 0.374
-
Opening the "Dor," Not Always an Inferior Approach. ASAIO J. 2019 07; 65(5):e50-e51.
Score: 0.352
-
Impact of Center Left Ventricular Assist Device Volume on Outcomes After Implantation: An INTERMACS Analysis. JACC Heart Fail. 2017 10; 5(10):691-699.
Score: 0.311
-
INTERMACS profiles and modifiers: Heterogeneity of patient classification and the impact of modifiers on predicting patient outcome. J Heart Lung Transplant. 2016 Apr; 35(4):440-8.
Score: 0.274
-
Early elevations in pump power with the HeartMate II left ventricular assist device do not predict late adverse events. J Heart Lung Transplant. 2014 Aug; 33(8):809-15.
Score: 0.243
-
Increasing Utilization of Extended Criteria Donor Hearts for Transplantation: The OCS Heart EXPAND Trial. JACC Heart Fail. 2024 Mar; 12(3):438-447.
Score: 0.121
-
Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device. J Am Coll Cardiol. 2023 08 29; 82(9):771-781.
Score: 0.118
-
Left Ventricular Assist Device and the Current State of the Art: HeartMate 3 at 5 Years. Heart Fail Clin. 2024 Jan; 20(1):83-89.
Score: 0.116
-
Adverse Hemodynamic Consequences of Continuous Left Ventricular Mechanical Support: JACC Review Topic of the Week. J Am Coll Cardiol. 2023 07 04; 82(1):70-81.
Score: 0.116
-
Status One and Status Two Exception Use in the Updated Heart Allocation System. J Card Fail. 2023 06; 29(6):963-967.
Score: 0.114
-
The prognostic role of advanced hemodynamic variables in patients with left ventricular assist devices. Artif Organs. 2023 Mar; 47(3):574-581.
Score: 0.111
-
Five-Year Outcomes in Patients With Fully Magnetically Levitated vs Axial-Flow Left Ventricular Assist Devices in the MOMENTUM 3 Randomized Trial. JAMA. 2022 09 27; 328(12):1233-1242.
Score: 0.110
-
Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio. J Thorac Cardiovasc Surg. 2023 12; 166(6):1684-1694.e18.
Score: 0.107
-
Global best practices consensus: Long-term management of patients with hybrid centrifugal flow left ventricular assist device support. J Thorac Cardiovasc Surg. 2022 10; 164(4):1120-1137.e2.
Score: 0.107
-
Outcomes in Smaller Body Size Adults After HeartMate 3 Left Ventricular Assist Device Implantation. Ann Thorac Surg. 2022 12; 114(6):2262-2269.
Score: 0.107
-
HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations. J Thorac Cardiovasc Surg. 2022 06; 163(6):2120-2127.e5.
Score: 0.106
-
Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants. Eur J Heart Fail. 2021 08; 23(8):1392-1400.
Score: 0.100
-
The use of enoxaparin as bridge to therapeutic INR after LVAD implantation. J Cardiothorac Surg. 2020 Nov 14; 15(1):329.
Score: 0.097
-
Impact of left ventricular assist device implantation on mitral regurgitation: An analysis from the MOMENTUM 3 trial. J Heart Lung Transplant. 2020 06; 39(6):529-537.
Score: 0.093
-
A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report. N Engl J Med. 2019 04 25; 380(17):1618-1627.
Score: 0.086
-
Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study. Circulation. 2019 01 08; 139(2):155-168.
Score: 0.085
-
Left Lateral Thoracotomy for Centrifugal Continuous-Flow Left Ventricular Assist Device Placement: An Analysis from the Mechanical Circulatory Support Research Network. ASAIO J. 2018 Nov/Dec; 64(6):715-720.
Score: 0.084
-
Healthcare Resource Use and Cost Implications in the MOMENTUM 3 Long-Term Outcome Study. Circulation. 2018 10 30; 138(18):1923-1934.
Score: 0.084
-
Outcomes with the Tandem Protek Duo Dual-Lumen Percutaneous Right Ventricular Assist Device. ASAIO J. 2018 Jul/Aug; 64(4):570-572.
Score: 0.082
-
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure. N Engl J Med. 2018 Apr 12; 378(15):1386-1395.
Score: 0.080
-
Impact of age, sex, therapeutic intent, race and severity of advanced heart failure on short-term principal outcomes in the MOMENTUM 3 trial. J Heart Lung Transplant. 2018 01; 37(1):7-14.
Score: 0.079
-
Temporal Differences in Outcomes During Long-Term Mechanical Circulatory Support. J Card Fail. 2017 Dec; 23(12):852-858.
Score: 0.077
-
Left Ventricular Assist Devices for Advanced Heart Failure. N Engl J Med. 2017 05 11; 376(19):1894-5.
Score: 0.076
-
Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure. Circulation. 2017 May 23; 135(21):2003-2012.
Score: 0.075
-
A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure. N Engl J Med. 2017 02 02; 376(5):440-450.
Score: 0.073
-
Ventricular Assist Device Therapy in Older Patients With Heart Failure: Characteristics and Outcomes. J Card Fail. 2016 Dec; 22(12):981-987.
Score: 0.073
-
Outcomes of Patients Receiving Temporary Circulatory Support Before Durable Ventricular Assist Device. Ann Thorac Surg. 2017 Jan; 103(1):106-112.
Score: 0.072
-
The HVAD Left Ventricular Assist Device: Risk Factors for Neurological Events and Risk Mitigation Strategies. JACC Heart Fail. 2015 Oct; 3(10):818-28.
Score: 0.068
-
Impact of concurrent surgical valve procedures in patients receiving continuous-flow devices. J Thorac Cardiovasc Surg. 2014 Feb; 147(2):581-9; discussion 589.
Score: 0.061
-
Successful management of asystole with an isolated left ventricular assist device. J Heart Lung Transplant. 2006 Apr; 25(4):490-2.
Score: 0.035
-
Impact of Patient Distance From Ventricular Assist Device-Implanting Center on Short- and Long-Term Outcomes. ASAIO J. 2018 Nov/Dec; 64(6):721-726.
Score: 0.021
-
Bleeding Complication Rates Are Higher in Females after Continuous-Flow Left Ventricular Assist Device Implantation. ASAIO J. 2018 Nov/Dec; 64(6):748-753.
Score: 0.021
-
A tale of the twist in the outflow graft: An analysis from the MOMENTUM 3 trial. J Heart Lung Transplant. 2018 11; 37(11):1281-1284.
Score: 0.021